Janus Henderson Group
TEVA icon

Janus Henderson Group’s Teva Pharmaceuticals TEVA Stock Holding History

Janus Henderson Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145M Buy
4,816,657
+72,880
+2% +$2.34M 0.07% 241
2025
Q4 		$148M Sell
4,743,777
-59,696
-1% -$1.47M 0.07% 224
2025
Q3 		$97M Sell
4,803,473
-361,417
-7% -$6.35M 0.04% 282
2025
Q2 		$86.6M Sell
5,164,890
-913,351
-15% -$14.7M 0.04% 291
2025
Q1 		$91.7M Sell
6,078,241
-659,384
-10% -$11.8M 0.05% 276
2024
Q4 		$148M Buy
6,737,625
+1,945,688
+41% +$35.4M 0.08% 227
2024
Q3 		$86.4M Buy
4,791,937
+4,732,374
+7,945% +$82.8M 0.04% 297
2024
Q2 		$968K Hold
59,563
– – ﹤0.01% 1635
2024
Q1 		$840K Hold
59,563
– – ﹤0.01% 1739
2023
Q4 		$622K Hold
59,563
– – ﹤0.01% 1890
2023
Q3 		$607K Sell
59,563
-6,943
-10% -$64.6K ﹤0.01% 1834
2023
Q2 		$500K Sell
66,506
-12,004
-15% -$97.3K ﹤0.01% 1979
2023
Q1 		$694K Hold
78,510
– – ﹤0.01% 1839
2022
Q4 		$716K Sell
78,510
-78,510
-50% -$685K ﹤0.01% 1534
2022
Q3 		$1.27M Buy
157,020
+78,510
+100% +$694K ﹤0.01% 1525
2022
Q2 		$591K Sell
78,510
-174,923
-69% -$1.52M ﹤0.01% 1662
2022
Q1 		$2.38M Buy
253,433
+25,780
+11% +$215K ﹤0.01% 1178
2021
Q4 		$1.82M Hold
227,653
– – ﹤0.01% 1295
2021
Q3 		$2.22M Sell
227,653
-22,436
-9% -$210K ﹤0.01% 1227
2021
Q2 		$2.48M Buy
250,089
+41,616
+20% +$440K ﹤0.01% 1197
2021
Q1 		$2.41M Buy
208,473
+5,326
+3% +$61.1K ﹤0.01% 1148
2020
Q4 		$1.96M Sell
203,147
-21,244
-9% -$204K ﹤0.01% 1127
2020
Q3 		$2.02M Buy
224,391
+33,114
+17% +$350K ﹤0.01% 1056
2020
Q2 		$2.36M Buy
191,277
+63,790
+50% +$721K ﹤0.01% 1009
2020
Q1 		$1.14M Sell
127,487
-170,377
-57% -$1.75M ﹤0.01% 1084
2019
Q4 		$2.92M Sell
297,864
-367,784
-55% -$3.28M ﹤0.01% 1124
2019
Q3 		$4.58M Sell
665,648
-688,287
-51% -$5.27M ﹤0.01% 1067
2019
Q2 		$12.5M Buy
1,353,935
+1,100,481
+434% +$13.3M 0.01% 900
2019
Q1 		$3.97M Sell
253,454
-1,033,267
-80% -$18.2M ﹤0.01% 1041
2018
Q4 		$19.8M Buy
1,286,721
+1,145,300
+810% +$23.5M 0.01% 751
2018
Q3 		$3.05M Buy
141,421
+14,500
+11% +$337K ﹤0.01% 1107
2018
Q2 		$3.09M Hold
126,921
– – ﹤0.01% 1094
2018
Q1 		$2.17M Hold
126,921
– – ﹤0.01% 1153
2017
Q4 		$2.41M Sell
126,921
-115
-0.1% -$1.73K ﹤0.01% 1099
2017
Q3 		$2.23M Sell
127,036
-3,011,051
-96% -$67.7M ﹤0.01% 1103
2017
Q2 		$104M Sell
3,138,087
-740,856
-19% -$22.9M 0.07% 343
2017
Q1 		$124M Sell
3,878,943
-4,227,409
-52% -$144M 0.87% 16
2016
Q4 		$294M Buy
8,106,352
+253,376
+3% +$10.1M 2.17% 4
2016
Q3 		$361M Buy
7,852,976
+185,562
+2% +$9.68M 2.66% 3
2016
Q2 		$385M Buy
7,667,414
+2,130,847
+38% +$113M 3.2% 1
2016
Q1 		$296M Buy
5,536,567
+966,585
+21% +$56.7M 2.4% 3
2015
Q4 		$300M Buy
4,569,982
+2,312,491
+102% +$143M 2.41% 3
2015
Q3 		$127M Buy
2,257,491
+408,465
+22% +$26.5M 1.12% 11
2015
Q2 		$109M Sell
1,849,026
-193,444
-9% -$11.9M 0.86% 12
2015
Q1 		$127M Sell
2,042,470
-19,363
-0.9% -$1.13M 0.98% 12
2014
Q4 		$119M Sell
2,061,833
-38,110
-2% -$2.12M 0.85% 17
2014
Q3 		$113M Buy
2,099,943
+563,830
+37% +$29.9M 1.06% 17
2014
Q2 		$80.5M Buy
1,536,113
+127,930
+9% +$6.54M 0.75% 25
2014
Q1 		$74.4M Buy
1,408,183
+466,030
+49% +$21.5M 0.72% 27
2013
Q4 		$37.8M Buy
942,153
+636,900
+209% +$25.1M 0.38% 68
2013
Q3 		$11.5M Buy
305,253
+15,160
+5% +$591K 0.13% 179
2013
Q2 		$11.3M Buy
+290,093
New +$11.3M 0.13% 167

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's TEVA Position: Q1 2026 in Review

Janus Henderson Group increased its Teva Pharmaceuticals (TEVA) stake by 1.5% in Q1 2026, buying an estimated $2.34M and bringing the position to 4,816,657 shares worth $145M. The position accounts for 0.07% of the portfolio, ranked #241.

Janus Henderson Group first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $385M in Q2 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Janus Henderson Group held 4,816,657 shares of Teva Pharmaceuticals worth $145M as of Q1 2026.
  • Janus Henderson Group bought 72,880 Teva Pharmaceuticals shares in Q1 2026, an estimated $2.34M.
  • Teva Pharmaceuticals made up 0.07% of Janus Henderson Group's portfolio in Q1 2026, its #241 holding.
  • Janus Henderson Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Teva Pharmaceuticals position peaked at $385M in Q2 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.